Publications by authors named "Launce Gouw"

Claim this Profile
E
Extended spectrum cephalosporin resistant enterobacteriaceae carriage and infection in patients admitted with newly-diagnosed acute leukemia.
Clyde D Ford, Bert K Lopansri, Jana Coombs, Launce Gouw, Julie Asch

Am J Infect Control· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful administration of chimeric antigen receptor (CAR) T-cell therapy in patients requiring hemodialysis.
Bradley D Hunter, Daanish Hoda, Andy Nguyen, Launce Gouw, Bryan Huber

Exp Hematol Oncol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clostridioides difficile colonization and infection in patients with newly diagnosed acute leukemia: Incidence, risk factors, and patient outcomes.
Clyde D Ford, Bert K Lopansri, Brandon J Webb, Jana Coombs, Launce Gouw

Am J Infect Control· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SCF-KIT signaling induces endothelin-3 synthesis and secretion: Thereby activates and regulates endothelin-B-receptor for generating temporally- and spatially-precise nitric oxide to modulate SCF- and or KIT-expressing cell functions.
Lei L Chen, Jing Zhu, Jonathan Schumacher, Chongjuan Wei, Latha Ramdas, Launce Gouw

PLoS One· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of amrubicin (SM-5887), a synthetic 9-aminoanthracycline, as first line treatment in patients with metastatic or unresectable soft tissue sarcoma: durable response in myxoid liposarcoma with TLS-CHOP translocation.
Sumati Gupta, Launce Gouw, Jennifer Wright, Sant Chawla, Debbie Pitt

Invest New Drugs· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigational Aurora A kinase inhibitor alisertib (MLN8237) as an enteric-coated tablet formulation in non-hematologic malignancies: phase 1 dose-escalation study.
Gerald Falchook, Razelle Kurzrock, Launce Gouw, David Hong, Kimberly A McGregor

Invest New Drugs· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining targeted therapy with immunotherapy (interferon-α): Rational, efficacy in gastrointestinal stromal tumor model and implications in other malignancies.
Lei L Chen, Launce Gouw, Mahyar Sabripour, Wen-Jen Hwu, Robert S Benjamin

Oncoimmunology· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploiting antitumor immunity to overcome relapse and improve remission duration.
Lei L Chen, Xinjian Chen, Haesun Choi, Hongxun Sang, Leo C Chen, Launce Gouw

Cancer Immunol Immunother· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sarcoma immunotherapy.
Launce G Gouw, Kevin B Jones, Sunil Sharma, R Lor Randall

Cancers (Basel)· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteolytic cleavage of ataxin-7 by caspase-7 modulates cellular toxicity and transcriptional dysregulation.
Jessica E Young, Launce Gouw, Stephanie Propp, Bryce L Sopher, Jillian Taylor

J Biol Chem· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of the Rho-family GTPase gene RHOF in lymphocyte subsets and malignant lymphomas.
Launce G Gouw, N Scott Reading, Stephen D Jenson, Megan S Lim, Kojo S J Elenitoba-Johnson

Br J Haematol· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis